Blood test for early cancer detection: the NOMAD study
Part of Blood & lymphatic, Cancer clinical trials.
This study is testing a new blood test to look for early signs of cancer in people without a past cancer diagnosis. You would give blood, urine, and saliva samples to help researchers see if the test works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must not have ever had cancer (other than common skin cancers like basal or squamous cell).
- You cannot have had an organ transplant.
- You must be able to provide a urine sample and not have a catheter or a recent urinary tract infection.
- You must be able to provide a saliva sample and not have a dry mouth condition or a recent cold/sore throat.
- You will be asked about your age, sex, and health history like diabetes, lung disease, and smoking.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether simple blood, tissue, and urine samples can help find cancer earlier and identify where it started. Participating could help improve future cancer detection for everyone.
This study collects blood from people with cancer and people without cancer (or with possible cancer) to test whether new blood tests can detect cancer earlier. Your blood samples help researchers evaluate how well these tests work.
This study is testing a new blood test that may help find cancer early. You will give blood samples over a year, and researchers will check them for signs of cancer.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
This trial tests a new blood test that may find early signs of cancer in people who have no symptoms. If you join, you'll have a blood draw, and the study will check if the test can catch cancer early.
This study looks at a non-invasive blood test to detect cancer-related “signal patterns” and see how well they match different types of cancer. It may help researchers learn better ways to find or understand cancer using less invasive testing.
Hear when a new Hematopoietic and Lymphoid System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.